University of Sussex
Browse
Methods to disinfect and decontaminate SARS-CoV-2 a systematic review of iin vitroi studies.pdf (673.35 kB)

Methods to disinfect and decontaminate SARS-CoV-2: a systematic review of in vitro studies

Download (673.35 kB)
journal contribution
posted on 2023-06-10, 00:34 authored by Chung Shing Kwok, Mustafa Dashti, Jacopo Tafuro, Mojtaba NasiriMojtaba Nasiri, Elena-Andra Muntean, Nicholas Wong, Timothy Kemp, George Hills, Christian D Mallen
Background: Cleaning is a major control component for outbreaks of infection. However, for the SARS-CoV-2 pandemic, there is limited specific guidance regarding the proper disinfection methods that should be used. Methods: We conducted a systematic review of the literature on cleaning, disinfection or decontamination methods in the prevention of SARS-CoV-2. Results: A total of 27 studies were included, reporting a variety of methods with which the effectiveness of interventions were assessed. Virus was inoculated onto different types of material including masks, nasopharyngeal swabs, serum, laboratory plates and simulated saliva, tears or nasal fluid and then interventions were applied in an attempt to eliminate the virus including chemical, ultraviolet (UV) light irradiation, and heat and humidity. At body temperature (37°C) there is evidence that the virus will not be detectable after 2?days but this can be reduced to non-detection at 30?min at 56°C, 15?min at 65°C and 2?min at 98°C. Different experimental methods testing UV light have shown that it can inactivate the virus. Light of 254–365?nm has been used, including simulated sunlight. Many chemical agents including bleach, hand sanitiser, hand wash, soap, ethanol, isopropanol, guandinium thiocynate/t-octylphenoxypolyethoxyethanol, formaldehyde, povidone-iodine, 0.05% chlorhexidine, 0.1% benzalkonium chloride, acidic electrolysed water, Clyraguard copper iodine complex and hydrogen peroxide vapour have been shown to disinfect SARS-CoV-2. Conclusions: Heating, UV light irradiation and chemicals can be used to inactivate SARS-CoV-2 but there is insufficient evidence to support one measure over others in clinical practice.

History

Publication status

  • Published

File Version

  • Published version

Journal

Therapeutic Advances in Infectious Disease

ISSN

2049-9361

Publisher

SAGE Publications

Volume

8

Page range

1-12

Event location

England

Department affiliated with

  • Biochemistry Publications

Full text available

  • Yes

Peer reviewed?

  • Yes

Legacy Posted Date

2021-08-09

First Open Access (FOA) Date

2021-08-09

First Compliant Deposit (FCD) Date

2021-08-06

Usage metrics

    University of Sussex (Publications)

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC